- Home
- PTIX vs EVOK Comparison
PTIX vs EVOK Comparison
Compare PTIX & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTIX
- EVOK
- Stock Information
- Founded
- PTIX 1994
- EVOK 2007
- Country
- PTIX United States
- EVOK United States
- Employees
- PTIX N/A
- EVOK N/A
- Industry
- PTIX Biotechnology: Pharmaceutical Preparations
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- PTIX Health Care
- EVOK Health Care
- Exchange
- PTIX Nasdaq
- EVOK Nasdaq
- Market Cap
- PTIX 6.3M
- EVOK 5.4M
- IPO Year
- PTIX 2016
- EVOK 2013
- Fundamental
- Price
- PTIX $3.32
- EVOK $4.80
- Analyst Decision
- PTIX
- EVOK
- Analyst Count
- PTIX 0
- EVOK 0
- Target Price
- PTIX N/A
- EVOK N/A
- AVG Volume (30 Days)
- PTIX 109.1K
- EVOK 30.9K
- Earning Date
- PTIX 11-13-2025
- EVOK 11-06-2025
- Dividend Yield
- PTIX N/A
- EVOK N/A
- EPS Growth
- PTIX N/A
- EVOK N/A
- EPS
- PTIX N/A
- EVOK N/A
- Revenue
- PTIX N/A
- EVOK $12,794,859.00
- Revenue This Year
- PTIX N/A
- EVOK $57.38
- Revenue Next Year
- PTIX N/A
- EVOK $59.57
- P/E Ratio
- PTIX N/A
- EVOK N/A
- Revenue Growth
- PTIX N/A
- EVOK 70.02
- 52 Week Low
- PTIX $2.25
- EVOK $1.94
- 52 Week High
- PTIX $15.26
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- PTIX 44.99
- EVOK 43.60
- Support Level
- PTIX $3.22
- EVOK $4.23
- Resistance Level
- PTIX $3.53
- EVOK $4.94
- Average True Range (ATR)
- PTIX 0.31
- EVOK 0.30
- MACD
- PTIX -0.09
- EVOK -0.06
- Stochastic Oscillator
- PTIX 10.53
- EVOK 46.36
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.